| Background: | Indoleamine 2,3-dioxygenase (IDO) is the rate-limiting and first enzyme of the L-tryptophan (L-Trp)-kynurenine pathway that converts the essential amino acid L-Trp to N-formylkynurenine in mammalian extrahepatic tissues. IDO is induced by pro-inflammatory |
| Clonality: | Monoclonal |
| Clone Number: | MOID86 |
| Formulation: | PBS/50% glycerol, pH 7.2 |
| Gene ID Human: | 3620 |
| Host Species: | Mouse |
| Immunogen: | Human IDO, full length |
| Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
| Isotype: | IgG1 kappa |
| Product Type: | Primary Antibody |
| Shipping: | 4 |
| Size: | 100 ug/100 uL |
| Source: | Purified IgG from hybridoma supernatant |
| Species Reactivities: | Human |
| Status: | RUO |
| Storage: | -20℃ |
| Target: | IDO |
Applications: FCM, IH, WB
| FCM: | 13.3 μg/mL (F(ab')2 fragmented) |
| IHC: | 0.4 μg/mL (F(ab')2 fragmented) |
| WB: | 1 μg/mL |
Puccetti, P., et al., Nat. Rev. Immunol. 7, 817-823 (2007), Pallotta, M. T., et al., Nat. Immunol. 12, 870-878 (2011), Hoshi, M., et al., J. Immunol. 185, 3305-3312 (2010), Hoshi, M., et al., J. Immunol. 188, 3980-3987 (2012)
